Cargando…

Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis

OBJECTIVE: To explore the intrinsic role of inhibitor of DNA binding 1 (ID‐1) in rheumatoid arthritis (RA) fibroblast‐like synoviocytes (FLS) and to investigate whether ID‐1 is citrullinated and autoantigenic in RA. METHODS: RA patient serum ID‐1 levels were measured before and after infliximab trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohara, Ray A., Edhayan, Gautam, Rasmussen, Stephanie M., Isozaki, Takeo, Remmer, Henriette A., Lanigan, Thomas M., Campbell, Phillip L., Urquhart, Andrew G., Lawton, Jeffrey N., Chung, Kevin C., Fox, David A., Ruth, Jeffrey H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663620/
https://www.ncbi.nlm.nih.gov/pubmed/30861322
http://dx.doi.org/10.1002/art.40886
_version_ 1783439793379606528
author Ohara, Ray A.
Edhayan, Gautam
Rasmussen, Stephanie M.
Isozaki, Takeo
Remmer, Henriette A.
Lanigan, Thomas M.
Campbell, Phillip L.
Urquhart, Andrew G.
Lawton, Jeffrey N.
Chung, Kevin C.
Fox, David A.
Ruth, Jeffrey H.
author_facet Ohara, Ray A.
Edhayan, Gautam
Rasmussen, Stephanie M.
Isozaki, Takeo
Remmer, Henriette A.
Lanigan, Thomas M.
Campbell, Phillip L.
Urquhart, Andrew G.
Lawton, Jeffrey N.
Chung, Kevin C.
Fox, David A.
Ruth, Jeffrey H.
author_sort Ohara, Ray A.
collection PubMed
description OBJECTIVE: To explore the intrinsic role of inhibitor of DNA binding 1 (ID‐1) in rheumatoid arthritis (RA) fibroblast‐like synoviocytes (FLS) and to investigate whether ID‐1 is citrullinated and autoantigenic in RA. METHODS: RA patient serum ID‐1 levels were measured before and after infliximab treatment. RA FLS were transfected with a clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR‐associated protein 9 construct targeting ID‐1 to examine the effects of ID‐1 deletion. RA synovial fluid (SF) and homogenized synovial tissue (ST) were immunoprecipitated for ID‐1 and measured for citrullinated residues using an enzyme‐linked immunosorbent assay and Western blotting. Liquid chromatography tandem mass spectrometry (LC‐MS/MS) was performed on in vitro–citrullinated recombinant human ID‐1 (cit–ID‐1) to localize the sites of citrullination. Normal and RA sera and SF were analyzed by immunodot blotting for anti–citrullinated protein antibodies (ACPAs) to cit–ID‐1. RESULTS: RA patient serum ID‐1 levels positively correlated with several disease parameters and were reduced after infliximab treatment. RA FLS displayed reduced growth and a robust increase in interleukin‐6 (IL‐6) and IL‐8 production upon deletion of ID‐1. ID‐1 immunodepletion significantly reduced the levels of citrullinated residues in RA SF, and citrullinated ID‐1 was detected in homogenized RA ST (n = 5 samples; P < 0.05). Immunodot blot analyses revealed ACPAs to cit–ID‐1 but not to native ID‐1, in RA peripheral blood (PB) sera (n = 30 samples; P < 0.001) and SF (n = 18 samples; P < 0.05) but not in normal PB sera. Following analyses of LC‐MS/MS results for citrullination sites and corresponding reactivity in immunodot assays, we determined the critical arginines in ID‐1 for autoantigenicity: R33, R52, and R121. CONCLUSION: Novel roles of ID‐1 in RA include regulation of FLS proliferation and cytokine secretion as well as autoantigenicity following citrullination.
format Online
Article
Text
id pubmed-6663620
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66636202019-10-07 Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis Ohara, Ray A. Edhayan, Gautam Rasmussen, Stephanie M. Isozaki, Takeo Remmer, Henriette A. Lanigan, Thomas M. Campbell, Phillip L. Urquhart, Andrew G. Lawton, Jeffrey N. Chung, Kevin C. Fox, David A. Ruth, Jeffrey H. Arthritis Rheumatol Rheumatoid Arthritis OBJECTIVE: To explore the intrinsic role of inhibitor of DNA binding 1 (ID‐1) in rheumatoid arthritis (RA) fibroblast‐like synoviocytes (FLS) and to investigate whether ID‐1 is citrullinated and autoantigenic in RA. METHODS: RA patient serum ID‐1 levels were measured before and after infliximab treatment. RA FLS were transfected with a clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR‐associated protein 9 construct targeting ID‐1 to examine the effects of ID‐1 deletion. RA synovial fluid (SF) and homogenized synovial tissue (ST) were immunoprecipitated for ID‐1 and measured for citrullinated residues using an enzyme‐linked immunosorbent assay and Western blotting. Liquid chromatography tandem mass spectrometry (LC‐MS/MS) was performed on in vitro–citrullinated recombinant human ID‐1 (cit–ID‐1) to localize the sites of citrullination. Normal and RA sera and SF were analyzed by immunodot blotting for anti–citrullinated protein antibodies (ACPAs) to cit–ID‐1. RESULTS: RA patient serum ID‐1 levels positively correlated with several disease parameters and were reduced after infliximab treatment. RA FLS displayed reduced growth and a robust increase in interleukin‐6 (IL‐6) and IL‐8 production upon deletion of ID‐1. ID‐1 immunodepletion significantly reduced the levels of citrullinated residues in RA SF, and citrullinated ID‐1 was detected in homogenized RA ST (n = 5 samples; P < 0.05). Immunodot blot analyses revealed ACPAs to cit–ID‐1 but not to native ID‐1, in RA peripheral blood (PB) sera (n = 30 samples; P < 0.001) and SF (n = 18 samples; P < 0.05) but not in normal PB sera. Following analyses of LC‐MS/MS results for citrullination sites and corresponding reactivity in immunodot assays, we determined the critical arginines in ID‐1 for autoantigenicity: R33, R52, and R121. CONCLUSION: Novel roles of ID‐1 in RA include regulation of FLS proliferation and cytokine secretion as well as autoantigenicity following citrullination. John Wiley and Sons Inc. 2019-06-21 2019-08 /pmc/articles/PMC6663620/ /pubmed/30861322 http://dx.doi.org/10.1002/art.40886 Text en © 2019 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Rheumatoid Arthritis
Ohara, Ray A.
Edhayan, Gautam
Rasmussen, Stephanie M.
Isozaki, Takeo
Remmer, Henriette A.
Lanigan, Thomas M.
Campbell, Phillip L.
Urquhart, Andrew G.
Lawton, Jeffrey N.
Chung, Kevin C.
Fox, David A.
Ruth, Jeffrey H.
Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis
title Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis
title_full Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis
title_fullStr Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis
title_full_unstemmed Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis
title_short Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis
title_sort citrullinated inhibitor of dna binding 1 is a novel autoantigen in rheumatoid arthritis
topic Rheumatoid Arthritis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663620/
https://www.ncbi.nlm.nih.gov/pubmed/30861322
http://dx.doi.org/10.1002/art.40886
work_keys_str_mv AT ohararaya citrullinatedinhibitorofdnabinding1isanovelautoantigeninrheumatoidarthritis
AT edhayangautam citrullinatedinhibitorofdnabinding1isanovelautoantigeninrheumatoidarthritis
AT rasmussenstephaniem citrullinatedinhibitorofdnabinding1isanovelautoantigeninrheumatoidarthritis
AT isozakitakeo citrullinatedinhibitorofdnabinding1isanovelautoantigeninrheumatoidarthritis
AT remmerhenriettea citrullinatedinhibitorofdnabinding1isanovelautoantigeninrheumatoidarthritis
AT laniganthomasm citrullinatedinhibitorofdnabinding1isanovelautoantigeninrheumatoidarthritis
AT campbellphillipl citrullinatedinhibitorofdnabinding1isanovelautoantigeninrheumatoidarthritis
AT urquhartandrewg citrullinatedinhibitorofdnabinding1isanovelautoantigeninrheumatoidarthritis
AT lawtonjeffreyn citrullinatedinhibitorofdnabinding1isanovelautoantigeninrheumatoidarthritis
AT chungkevinc citrullinatedinhibitorofdnabinding1isanovelautoantigeninrheumatoidarthritis
AT foxdavida citrullinatedinhibitorofdnabinding1isanovelautoantigeninrheumatoidarthritis
AT ruthjeffreyh citrullinatedinhibitorofdnabinding1isanovelautoantigeninrheumatoidarthritis